[Adimmune] Announcement of Important Resolutions at the 2026 Annual General Meeting
Adimmune Corporation held its annual general meeting on June 4, 2026, approving the business report, financial statements, and loss compensation proposal for the previous fiscal year.
📋 Article Processing Timeline
- 📰 Published: June 4, 2026 at 09:00
- 🔍 Collected: June 5, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: June 7, 2026 at 06:14 (46h 14m after Collected)
1. Date of the Annual General Meeting: 2026/06/04
2. Important Resolution 1, Surplus Distribution or Loss Compensation: Approval of the 2025 loss compensation proposal.
3. Important Resolution 2, Articles of Incorporation Amendment: None.
4. Important Resolution 3, Business Report and Financial Statements: Approval of the 2025 business report and financial statements.
5. Important Resolution 4, Election of Directors and Supervisors: None.
6. Important Resolution 5, Other Items: None.
7. Other Matters to be Stated: None.
2. Important Resolution 1, Surplus Distribution or Loss Compensation: Approval of the 2025 loss compensation proposal.
3. Important Resolution 2, Articles of Incorporation Amendment: None.
4. Important Resolution 3, Business Report and Financial Statements: Approval of the 2025 business report and financial statements.
5. Important Resolution 4, Election of Directors and Supervisors: None.
6. Important Resolution 5, Other Items: None.
7. Other Matters to be Stated: None.
FAQ
What were the main decisions at Adimmune's shareholder meeting?
The 2025 business report, financial statements, and loss compensation proposal were approved.
Were there any board elections?
No, there were no board director or supervisor elections held at this meeting.
What is the future outlook?
No specific strategy changes or future outlook details were provided in this announcement.